3-Hydroxy-1-(4-hydroxyphenyl)propan-1-oneCAS# 53170-93-7 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 53170-93-7 | SDF | Download SDF |
| PubChem ID | 638759 | Appearance | Powder |
| Formula | C9H10O3 | M.Wt | 166.17 |
| Type of Compound | Phenylpropanoid | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 3-hydroxy-1-(4-hydroxyphenyl)propan-1-one | ||
| SMILES | C1=CC(=CC=C1C(=O)CCO)O | ||
| Standard InChIKey | LTEPZFZSPZASKJ-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C9H10O3/c10-6-5-9(12)7-1-3-8(11)4-2-7/h1-4,10-11H,5-6H2 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
3-Hydroxy-1-(4-hydroxyphenyl)propan-1-one Dilution Calculator
3-Hydroxy-1-(4-hydroxyphenyl)propan-1-one Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 6.0179 mL | 30.0897 mL | 60.1793 mL | 120.3587 mL | 150.4483 mL |
| 5 mM | 1.2036 mL | 6.0179 mL | 12.0359 mL | 24.0717 mL | 30.0897 mL |
| 10 mM | 0.6018 mL | 3.009 mL | 6.0179 mL | 12.0359 mL | 15.0448 mL |
| 50 mM | 0.1204 mL | 0.6018 mL | 1.2036 mL | 2.4072 mL | 3.009 mL |
| 100 mM | 0.0602 mL | 0.3009 mL | 0.6018 mL | 1.2036 mL | 1.5045 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 14β,16β-Dihydroxy-3β-(β-D-glucopyranosyloxy)-5α-bufa-20,22-dienolide
Catalog No.:BCN9217
CAS No.:1323952-04-0
- Acutumine
Catalog No.:BCN9216
CAS No.:17088-50-5
- 3'-O-Methyltaxifolin
Catalog No.:BCN9215
CAS No.:55812-91-4
- 3α-Cinnamoyloxy-9β,17-dihydroxy-ent-kaur-15-en-19-oic acid
Catalog No.:BCN9214
CAS No.:2186648-60-0
- Loroglossin
Catalog No.:BCN9213
CAS No.:58139-22-3
- 3"-O-Desmethylspinorhamnoside
Catalog No.:BCN9212
CAS No.:2220243-41-2
- 6-O-(p-Hydroxybenzoyl)glucose
Catalog No.:BCN9211
CAS No.:202337-44-8
- Jacaranone
Catalog No.:BCN9210
CAS No.:60263-07-2
- Ethyl chlorogenate
Catalog No.:BCN9209
CAS No.:425408-42-0
- Chimaphilin
Catalog No.:BCN9208
CAS No.:482-70-2
- Qingyangshengenin 3-O-α-L-cymaropyranosyl-(1→4)-β-D-oleandropyranosyl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranoside
Catalog No.:BCN9207
CAS No.:1808159-02-5
- O-Demethylstachartin C
Catalog No.:BCN9206
CAS No.:1219361-60-0
- Ethyl 3-(4-hydroxyphenyl)propionate
Catalog No.:BCN9219
CAS No.:23795-02-0
- Nardoeudesmol A
Catalog No.:BCN9220
CAS No.:1445952-30-6
- Ajacine
Catalog No.:BCN9221
CAS No.:509-17-1
- 6,4'-Dihydroxy-7-methoxyflavan
Catalog No.:BCN9222
CAS No.:202463-50-1
- Desglucohellebrin
Catalog No.:BCN9223
CAS No.:20300-44-1
- 5,7-Dihydroxyphthalide
Catalog No.:BCN9224
CAS No.:27979-58-4
- (+)-Nyasol
Catalog No.:BCN9225
CAS No.:185020-38-6
- Sepiumol A
Catalog No.:BCN9226
CAS No.:2411999-52-3
- Delbonine
Catalog No.:BCN9227
CAS No.:95066-33-4
- Glabredelphinine
Catalog No.:BCN9228
CAS No.:132160-37-3
- (-)-Episyringaresinol
Catalog No.:BCN9229
CAS No.:6216-82-6
- N-Acetyldelectine
Catalog No.:BCN9230
CAS No.:63596-61-2
Phenolic compounds from the branches of Eucalyptus maideni.[Pubmed:22253109]
Chem Biodivers. 2012 Jan;9(1):123-30.
Three new phenolic compounds, eucalmaidin F (1), (3S)-5-guaiacyl-3-hydroxypentanoic acid (2), and 8-beta-C-glucopyranosyl-5,7-dihydroxy-2-isobutylchromone (3), were isolated from the branches of E. maideni, together with 30 known compounds, including four phenylpropanoids, three lignans, four phloroglucinol glucosides, five dihydroflavonoids, seven simple phenolic compounds, six terpenoids, and glycerol. The new structures were established by spectroscopic studies (MS, and 1D- and 2D-NMR), chemical degradation, and modified Mosher's method. Compounds 3, guaiacylglycerol, 3-Hydroxy-1-(4-hydroxyphenyl)propan-1-one, caffeic acid, (2E)-3-(4-hydroxyphenyl)prop-2-enoic acid, (7'S,8R,8'R)-lyoniresinol, (+)-lyoresinol 3alpha-O-alpha-L-rhamnopyranoside, garcimangosone, phlorocetophenone 2'-glucopyranoside, (+)-taxifolin 3alpha-O-alpha-L-rhamnopyranoside, (+)-aromadendrin, (+)-taxifolin, resveratrol, piceatannol, 3,4,5-trihydroxyphenol. Tachiaside, gallic acid, macrocapals A und G, and oleuropeic acid were evaluated for their cytotoxicities against five human cancer cell lines. Resveratrol, piceatannol, gallic acid, and macrocapal G exhibited moderate inhibitory effects on human myeloid heukemia HL-60 cell, with IC(50) values of 22.05, 22.05, 7.75, and 31.93 muM, respectively; and only macrocapal G showed inhibitory effect on hepatocellular carcinoma SMMC-7721 cell, with an IC(50) value of 26.75 muM.
